Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
7.71
+0.08 (1.05%)
Dec 9, 2025, 2:10 PM EST - Market open
Relay Therapeutics Revenue
Relay Therapeutics had revenue of $8.36M in the twelve months ending September 30, 2025, down -16.50% year-over-year. In the year 2024, Relay Therapeutics had annual revenue of $10.01M, down -60.83%.
Revenue (ttm)
$8.36M
Revenue Growth
-16.50%
P/S Ratio
155.35
Revenue / Employee
$32,011
Employees
261
Market Cap
1.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.01M | -15.54M | -60.83% |
| Dec 31, 2023 | 25.55M | 24.17M | 1,749.82% |
| Dec 31, 2022 | 1.38M | -1.65M | -54.41% |
| Dec 31, 2021 | 3.03M | -79.63M | -96.34% |
| Dec 31, 2020 | 82.65M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
RLAY News
- 6 days ago - Relay Therapeutics Director Sells $300,000 Worth of Shares. Here's Why Investors Shouldn't Panic. - The Motley Fool
- 6 days ago - Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares - The Motley Fool
- 17 days ago - Relay Therapeutics, Inc. (RLAY) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 5 weeks ago - Relay Therapeutics to Participate in Two Upcoming Investor Conferences in November - GlobeNewsWire
- 5 weeks ago - Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025 - GlobeNewsWire
- 6 weeks ago - Relay Therapeutics Is A Buy For Its Superb Safety Data - Seeking Alpha
- 3 months ago - Relay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha